Alligator Bioscience Appoints Johan Giléus as Chief Executive Officer
PRIVATEOct 05, 2026
Position
Chief Financial Officer
Company
Alligator Bioscience
Johan Giléus
LundBiotechnology
Description
Alligator Bioscience has announced the appointment of Johan Giléus as its new Chief Executive Officer, effective January 1, 2027. He will succeed Søren Bregenholt, who will continue as CEO until December 31, 2026. Johan will also retain his role as Chief Financial Officer as the company refocuses on its financial interests.
Company Information
Company
Alligator Bioscience
Location
Lund, Skåne County, Sweden
About
Alligator Bioscience is a biotechnology company focused on developing innovative antibody therapies primarily targeting cancer. The company specializes in the financial interest in the HER2-targeting antibody programme HLX22. Alligator aims to redirect its resources towards high-impact projects in the biotech sector. Through strategic leadership, it navigates the complex landscape of drug development.
Fundz sees it the moment Alligator Bioscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.